This Article Free Full Text (Free OnlineFirst PDF) All Versions of this Article: 0192623308322310v1 36/6/840    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Weaver, J. L. Articles by Hanig, J. Search for Related Content PubMed PubMed Citation Articles by Weaver, J. L. Articles by Hanig, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Vascular Diseases Social Bookmarking                         What's this?

Biomarkers in Peripheral Blood Associated with Vascular Injury in Sprague-Dawley Rats Treated with the Phosphodiesterase IV Inhibitors SCH 351591 or SCH 534385

^* To whom correspondence should be addressed. E-mail: James.Weaver{at}fda.hhs.gov.

	Abstract

Drug-associated vascular injury can be caused by phosphodiesterase (PDE) IV inhibitors and drugs from several other classes. The pathogenesis is poorly understood, but it appears to include vascular and innate immunological components. This research was undertaken to identify changes in peripheral blood associated with vascular injury caused by PDE IV inhibitors. We evaluated twelve proteins, serum nitrite, and leukocyte populations in peripheral blood of rats treated with experimental PDE IV inhibitors. We found that these compounds produced histological microvascular injury in a dose- and time-dependent manner. Measurement of these serum proteins showed changes in eight of the twelve examined. Changes were seen in the levels of: tissue inhibitor of metalloproteinase-1, 1-acid glycoprotein, GRO/CINC-1, vascular endothelial growth factor, C-reactive protein, haptoglobin, thrombomodulin, and interleukin-6. No changes were seen in levels of tumor necrosis factor-, hepatocyte growth factor, nerve growth factor, and granulocyte-monocyte colony stimulating factor. Serum levels of nitrite were also increased. Circulating granulocyte numbers were increased, and lymphocyte numbers were decreased. The changes in these parameters showed both a dose- and time-dependent association with histopathologic changes. These biomarkers could provide an additional tool for the nonclinical and clinical evaluation of investigational compounds.

First published on September 5, 2008, doi:10.1177/0192623308322310

Toxicologic Pathology 2008;36:840.

A more recent version of this article appeared on October 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Zhang, R. D. Snyder, E. H. Herman, A. Knapton, R. Honchel, T. Miller, P. Espandiari, F. M. Goodsaid, I. Y. Rosenblum, J. P. Hanig, et al. Histopathology of Vascular Injury in Sprague-Dawley Rats Treated with Phosphodiesterase IV Inhibitor SCH 351591 or SCH 534385 Toxicol Pathol, October 1, 2008; 36(6): 827 - 839. [Abstract] [Full Text] [PDF]